Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» gout
gout
Few signs of gout pipeline flaring up
Few signs of gout pipeline flaring up
EP Vantage
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Flag link:
Gout Disease Control Suffered After FDA-Driven Price Hike: Study
Gout Disease Control Suffered After FDA-Driven Price Hike: Study
BioSpace
FDA
gout
colchicine
drug pricing
Takeda
Colcrys
Flag link:
Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys
Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys
Fierce Pharma
Takeda
pay-for-delay
generics
gout
Colcrys
Flag link:
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Fierce Biotech
Sobi
Selecta Biosciences
gout
SEL-212
Horizon Therapeutics
Krystexxa
Flag link:
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Clinical Trials Arena
Atom Bioscience
gout
clinical trials
ABP-671
Flag link:
Krystexxa Chronic Gout Medication Gets Expanded FDA Approval
Krystexxa Chronic Gout Medication Gets Expanded FDA Approval
Xtalks
Horizon Therapeutics
Krystexxa
gout
FDA
Flag link:
Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med
Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med
Endpoints
Horizon Therapeutics
gout
Krystexxa
Arrowhead Pharmaceuticals
ARO-XDH
Flag link:
A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release
A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release
Stat
COVID-19
gout
colchicine
Flag link:
InventisBio reels in $147M to push gout and breast cancer drugs along
InventisBio reels in $147M to push gout and breast cancer drugs along
Endpoints
InventisBio
funding
breast cancer
gout
Flag link:
Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate
Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate
Pharmaceutical Business Review
Horizon Therapeutics
clinical trials
uncontrolled gout
gout
Krystexxa
Flag link:
FDA Warns of Increased Risk of Death With Gout Medicine Uloric
FDA Warns of Increased Risk of Death With Gout Medicine Uloric
RAPS.org
FDA
Uloric
Takeda
gout
Flag link:
Selecta lays off staff as R&D cash crunch looms
Selecta lays off staff as R&D cash crunch looms
Fierce Biotech
Selecta Biosciences
layoffs
R&D
SEL-212
gout
Flag link:
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Endpoints
AstraZeneca
gout
lesinurad
Ironwood
Flag link:
Public Citizen Calls on FDA to Withdraw Takeda Gout Drug
Public Citizen Calls on FDA to Withdraw Takeda Gout Drug
RAPS.org
Takeda
Public Citizen
gout
Uloric
Flag link:
Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Fierce Pharma
Krystexxa
Horizon Pharma
drug reps
gout
Flag link:
Ironwood zeroes in on primary care doctors with new gout combo med Duzallo
Ironwood zeroes in on primary care doctors with new gout combo med Duzallo
Fierce Pharma
Ironwood Pharmaceuticals
gout
Duzallo
primary care
Flag link:
Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo
Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo
Endpoints
Ironwood
gout
FDA
Duzallo
Flag link:
AZ jilts gout med Zurampic with $230M rights sale to Grunenthal
AZ jilts gout med Zurampic with $230M rights sale to Grunenthal
Fierce Pharma
AstraZeneca
gout
Zurampic
Grunenthal
Flag link:
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
BioPharma Dive
AstraZeneca
Zurampic
Ironwood Pharmaceuticals
gout
Flag link:
AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in sales
AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in sales
Fierce Pharma
AstraZeneca
Europe
gout
Zurampic
Brilique
Flag link:
Pages
1
2
3
4
next ›
last »